ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO1065

Association of Macronutrients with CKD Progression in West Africans

Session Information

Category: Health Maintenance, Nutrition, and Metabolism

  • 1500 Health Maintenance, Nutrition, and Metabolism

Authors

  • Kwakyi, Edward Papa Kwabena, University of Ghana Medical School, Accra, Greater Accra, Ghana
  • Zhao, Runqi, Boston Medical Center, Boston, Massachusetts, United States
  • Raji, Yemi R., University of Ibadan and University College Hospital, Ibadan, Nigeria
  • Mamven, Manmak, University of Abuja, Abuja, Federal Capital Territory, Nigeria
  • Adebile, Tolulope V., Boston Medical Center, Boston, Massachusetts, United States
  • Solarin, Adaobi, Lagos State University Teaching Hospital, Lagos, Lagos, Nigeria
  • Ripiye, Nanna R., University of Abuja, Abuja, Federal Capital Territory, Nigeria
  • Umeizudike, Theophilus I., Lagos State University Teaching Hospital, Lagos, Lagos, Nigeria
  • Ulasi, Ifeoma I., University of Nigeria, Nsukka, Enugu, Nigeria
  • Adu, Dwomoa, University of Ghana Medical School, Accra, Greater Accra, Ghana
  • Gbadegesin, Rasheed A., Duke University School of Medicine, Durham, North Carolina, United States
  • Parekh, Rulan S., Women's College Hospital, Toronto, Ontario, Canada
  • Ojo, Akinlolu, Kansas State University, Manhattan, Kansas, United States
  • Mitchell, Diane C., Texas A&M University System, College Station, Texas, United States
  • Waikar, Sushrut S., Boston Medical Center, Boston, Massachusetts, United States
  • Ilori, Titilayo O., Boston Medical Center, Boston, Massachusetts, United States
Background

Dietary modifications slow chronic kidney disease (CKD) progression. However, the association of macronutrients with CKD progression is not well understood.

Methods

We obtained 24h dietary recall data from participants in the Diet, Apolipoprotein L1 and CKD (DCA) study. We determined macronutrient consumption (g/day) for protein, carbohydrates, polyunsaturated fatty acids (PUFAs), monounsaturated fatty acids (MUFAs) and saturated fats; and expressed consumption in quartiles. Our outcome was the total eGFR slope over 3 years. We used a mixed effect linear regression model with the clinical center as a random effect to evaluate the association of macronutrient consumption with total eGFR slope. The results were expressed as beta coefficients with 95% confidence intervals.

Results

We analyzed data from 510 participants: mean age 49 (SD=18) years, 53% male, and mean eGFR was 71ml/min/1.73m2 (SD=39). In the adjusted models compared to the lowest quartiles of consumption (Q1), Q4 of carbohydrate consumption and PUFAs consumption were associated with a positive eGFR slope change; and saturated fats (Q4 vsQ1) was associated with eGFR slope decline. The p for trend was significant moving from lower to higher polyunsaturated fatty acid consumption (Table 1).

Conclusion

To our knowledge, this is the first study showing the association of macronutrients with CKD progression in a well-phenotyped West African CKD population. Our observations of a positive association between saturated fat consumption and CKD progression and a protective effect of PUFAs are consistent with previous publications. Carbohydrate consumption results were likely due to the higher quality carbohydrates consumed in West Africa.

Funding

  • NIDDK Support